Clinical Pharmacokinetics of Cyclophosphamide
Milly E. de Jonge(The Netherlands Cancer Institute), Jos H. Beijnen(Utrecht University), Alwin D. R. Huitema(The Netherlands Cancer Institute), Sjoerd Rodenhuis(The Netherlands Cancer Institute)
Cited by 451
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Mutational Activation of the K-<i>ras</i>Oncogene
|New England Journal of Medicine|1987|540